346 related articles for article (PubMed ID: 26621858)
41. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
42. Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation.
Cao J; Chen C; Zeng L; Li L; Li Z; Xu K
Leuk Res; 2010 Oct; 34(10):1374-82. PubMed ID: 20018376
[TBL] [Abstract][Full Text] [Related]
43. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
[TBL] [Abstract][Full Text] [Related]
44. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
45. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
46. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
Ewing P; Hildebrandt GC; Planke S; Andreesen R; Holler E; Gerbitz A
Int J Mol Med; 2007 Sep; 20(3):301-8. PubMed ID: 17671733
[TBL] [Abstract][Full Text] [Related]
47. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
[TBL] [Abstract][Full Text] [Related]
48. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
Chan GW; Gorgun G; Miller KB; Foss FM
Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
[TBL] [Abstract][Full Text] [Related]
50. [Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice].
Yang K; Liu QF; Fan ZP; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):547-52. PubMed ID: 17605863
[TBL] [Abstract][Full Text] [Related]
51. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation.
Gauthier SD; Leboeuf D; Manuguerra-Gagné R; Gaboury L; Guimond M
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1721-31. PubMed ID: 26151303
[TBL] [Abstract][Full Text] [Related]
52. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
[TBL] [Abstract][Full Text] [Related]
53. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
[TBL] [Abstract][Full Text] [Related]
54. Host-derived CD8⁺ dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation.
Weber M; Rudolph B; Stein P; Yogev N; Bosmann M; Schild H; Radsak MP
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1696-704. PubMed ID: 25132527
[TBL] [Abstract][Full Text] [Related]
55. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
[TBL] [Abstract][Full Text] [Related]
56. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
[TBL] [Abstract][Full Text] [Related]
57. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3787-94. PubMed ID: 16418327
[TBL] [Abstract][Full Text] [Related]
58. Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.
Semple K; Yu Y; Wang D; Anasetti C; Yu XZ
Biol Blood Marrow Transplant; 2011 Mar; 17(3):309-18. PubMed ID: 21224010
[TBL] [Abstract][Full Text] [Related]
59. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
Avivi I; Stroopinsky D; Rowe JM; Katz T
Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells.
Huang Y; Zhao Y; Ran X; Wang C
Mol Med Rep; 2014 Mar; 9(3):813-8. PubMed ID: 24366217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]